Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sustainability, affordability, and equity of corporate drug donations: the case of Malarone.

× No keyword cloud information.

7 in total

Review 1. Antiparasitic agent atovaquone.

Authors: Aaron L Baggish; David R Hill
Journal: Antimicrob Agents Chemother Date: 2002-05 Impact factor: 5.191

Review 2. Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors: Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal: Clin Microbiol Rev Date: 2004-07 Impact factor: 26.132

3. To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008.

Authors: Lisa Bero; Brittany Carson; Helene Moller; Suzanne Hill
Journal: Bull World Health Organ Date: 2010-08-27 Impact factor: 9.408

Review 4. Atovaquone-proguanil for treating uncomplicated malaria.

Authors: A Osei-Akoto; L Orton; S P O Owusu-Ofori
Journal: Cochrane Database Syst Rev Date: 2005-10-19

5. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.

Authors: Quinton L Fivelman; Geoffrey A Butcher; Ipemida S Adagu; David C Warhurst; Geoffrey Pasvol
Journal: Malar J Date: 2002-02-08 Impact factor: 2.979

6. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.

Authors: Tamirat Gebru; Asrat Hailu; Peter G Kremsner; Jürgen F J Kun; Martin P Grobusch
Journal: Malar J Date: 2006-11-21 Impact factor: 2.979

7. Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.

Authors: Geoffrey S Dow; Alan J Magill; Colin Ohrt
Journal: Ther Clin Risk Manag Date: 2008-08 Impact factor: 2.423

7 in total